scholarly journals Baseline characteristics in Japan‐multimodal intervention trial for prevention of dementia (J‐MINT) Tamba study

2021 ◽  
Vol 17 (S10) ◽  
Author(s):  
Rei Ono ◽  
Hisatomo Kowa ◽  
Yutaro Oki ◽  
Tohmi Osaki ◽  
Shunsuke Murata ◽  
...  
2000 ◽  
Vol 61 (4) ◽  
pp. 219-243 ◽  
Author(s):  
Yuji Matsuzawa ◽  
Hiroshige Itakura ◽  
Toru Kita ◽  
Hiroshi Mabuchi ◽  
Masunori Matsuzaki ◽  
...  

2008 ◽  
Vol 17 (7) ◽  
pp. 1099-1110 ◽  
Author(s):  
Marian L. Fitzgibbon ◽  
Melinda Stolley ◽  
Linda Schiffer ◽  
Lisa Sharp ◽  
Vicky Singh ◽  
...  

The Lancet ◽  
2017 ◽  
Vol 390 ◽  
pp. S13 ◽  
Author(s):  
Bo Bai ◽  
Zhongrui Yan ◽  
Yanlei Hao ◽  
Zuoji Zhang ◽  
Gongying Li ◽  
...  

2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Sigrid Beer-Borst ◽  
Xhyljeta Luta ◽  
Stefanie Hayoz ◽  
Kathrin Sommerhalder ◽  
Corinna Gréa Krause ◽  
...  

Author(s):  
T. Sugimoto ◽  
T. Sakurai ◽  
H. Akatsu ◽  
T. Doi ◽  
Y. Fujiwara ◽  
...  

Background/Objectives: The Japan-multimodal intervention trial for prevention of dementia (J-MINT) is intended to verify the effectiveness of multi-domain interventions and to clarify the mechanism of cognitive improvement and deterioration by carrying out assessment of dementia-related biomarkers, omics analysis and brain imaging analysis among older adults at high risk of dementia. Moreover, the J-MINT trial collaborates with partnering private enterprises in the implementation of relevant interventional measures. This manuscript describes the study protocol. Design/Setting: Eighteen-month, multi-centered, randomized controlled trial. Participants: We plan to recruit 500 older adults aged 65-85 years with mild cognitive impairment. Subjects will be centrally randomized into intervention and control groups at a 1:1 allocation ratio using the dynamic allocation method with all subjects stratified by age, sex, and cognition. Intervention: The multi-domain intervention program includes: (1) management of vascular risk factors; (2) group-based physical exercise and self-monitoring of physical activity; (3) nutritional counseling; and (4) cognitive training. Health-related information will be provided to the control group every two months. Measurements: The primary and secondary outcomes will be assessed at baseline, 6-, 12-, and 18-month follow-up. The primary outcome is the change from baseline to 18 months in a global composite score combining several neuropsychological domains. Secondary outcomes include: cognitive change in each neuropsychological test, incident dementia, changes in blood and dementia-related biomarkers, changes in geriatric assessment including activities of daily living, frailty status and neuroimaging, and number of medications taken. Conclusions: This trial that enlist the support of private enterprises will lead to the creation of new services for dementia prevention as well as to verify the effectiveness of multi-domain interventions for dementia prevention.


Sign in / Sign up

Export Citation Format

Share Document